AngioDynamics (NASDAQ:ANGO) Issues FY25 Earnings Guidance
AngioDynamics (NASDAQ:ANGO – Get Free Report) updated its FY25 earnings guidance on Thursday. The company provided EPS guidance of ($0.42)-($0.38) for the period, compared to the consensus EPS estimate of ($0.41). The company issued revenue guidance of $282-288 million, compared to the consensus revenue estimate of $284.37 million. AngioDynamics also updated its FY 2025 guidance […]
More Stories
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada...
CRISPR Therapeutics (NASDAQ:CRSP) Price Target Cut to $53.00
CRISPR Therapeutics (NASDAQ:CRSP – Get Free Report) had its price target reduced by equities researchers at Royal Bank of Canada...
Atmos Energy Co. (NYSE:ATO) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Atmos Energy Co. (NYSE:ATO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Atmos Energy Co. (NYSE:ATO) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Atmos Energy Co. (NYSE:ATO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the...
Analysts Set Tidewater Inc. (NYSE:TDW) Price Target at $111.25
Tidewater Inc. (NYSE:TDW – Get Free Report) has received an average rating of “Buy” from the five ratings firms that...
Analysts Set Tidewater Inc. (NYSE:TDW) Price Target at $111.25
Tidewater Inc. (NYSE:TDW – Get Free Report) has received an average rating of “Buy” from the five ratings firms that...